-       Report 
- December 2024
-  200 Pages 
- Global 
   From       €3354EUR$3,750USD£2,950GBP 
          -       Report 
- November 2024
-  120 Pages 
- Latin America 
   From       €5322EUR$5,950USD£4,681GBP 
            -       Report 
- October 2025
-  193 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- December 2020
-  64 Pages 
- United States 
   From       €760EUR$850USD£669GBP 
          -       Report 
- November 2020
-  82 Pages 
- North America 
   From       €5322EUR$5,950USD£4,681GBP 
              The Hemp Derived Cannabidiol (HDC) market is a rapidly growing segment of the Central Nervous System (CNS) drugs market. HDC is a non-psychoactive cannabinoid derived from hemp plants, and is used to treat a variety of conditions, including anxiety, depression, and chronic pain. HDC is gaining popularity due to its potential therapeutic benefits, as well as its lack of side effects. HDC is also being studied for its potential to treat neurological disorders, such as epilepsy and multiple    sclerosis.
The HDC market is expected to continue to grow as more research is conducted and more products become available. Companies are investing in research and development to create new products and formulations, as well as to expand their product lines.
Some companies in the HDC market include Charlotte's Web, Elixinol, and Endoca. These companies offer a variety of products, including tinctures, capsules, and topical creams. Additionally, many of these companies are involved in research and development, as well as education and advocacy. Show Less   Read more